Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | IDO1 | P14902 | 1/20 | 0.31 |
| ▸ | TDO2 | P48775 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25327676 | 0.87 | ALOX15 (0.41) | ALOX15ALOX12ALDH1A1TSHRIDO1 | |
| SCHEMBL25329288 | 0.86 | ALOX12 (0.43) | ALOX15ALOX12ALDH1A1TSHRIDO1 | |
| SCHEMBL25328780 | 0.85 | SCN5A (0.32) | ALOX15ALOX12ALDH1A1MAPT | |
| SCHEMBL25329818 | 0.81 | CYP3A4 (0.41) | ALOX15ALOX12ALDH1A1 | |
| SCHEMBL25327649 | 0.81 | ALOX15 (0.39) | ALOX15ALOX12ALDH1A1PTPN1 | |
| SCHEMBL10919487 | 0.79 | ALOX15 (0.35) | ALOX15ALOX12ALDH1A1TSHRMAPT | |
| SCHEMBL25328994 | 0.77 | ALOX15 (0.33) | ALOX15ALOX12 | |
| SCHEMBL25328745 | 0.77 | ALDH1A1 (0.35) | ALOX15ALOX12ALDH1A1MAPTPTPN1 | |
| SCHEMBL30356402 | 0.75 | THRA (0.38) | ALDH1A1MAPT | |
| SCHEMBL25327700 | 0.75 | SCN5A (0.32) | ALOX15ALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12583813-B2 | Polymerization inhibitors | BASF SE (DE) | 2026-03-24 | — | — | US | disclosed |
| US-20230242472-A1 | POLYMERIZATION INHIBITORS | BASF SE (DE) | 2023-08-03 | — | — | US | disclosed |
| EP-4161892-A1 | POLYMERIZATION INHIBITORS | BASF SE (DE) | 2023-04-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242472-A1 | POLYMERIZATION INHIBITORS | RCE1, CABLES1, DPYD | ALOX15 2186/4885ALOX12 1986/4885ALDH1A1 1314/4885 |
| US-12583813-B2 | Polymerization inhibitors | PTGS1, PTGER1, POT1 | ALOX15 615/4885ALOX12 211/4885ALDH1A1 32/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.